Richard S Levy insider trades: Madrigal Pharmaceuticals (MDGL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
44 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | MDGL | ↓ Sell | 5,682 | $515.44 | $2.9M | Direct | May 22, 2026 (0d) |
| Nov 13, 2025 | MDGL | ↓ Sell | 8,500 | $520.96 | $4.4M | Direct | Nov 14, 2025 (1d) |
| May 14, 2025 | TARA | ↑ Buy | 20,000 | $3.19 | $64K | Direct | May 16, 2025 (2d) |
| Nov 7, 2024 | MDGL | ↓ Sell | 5,000 | $350.00 | $1.8M | Direct | Nov 8, 2024 (1d) |
| Nov 1, 2024 | MDGL | ↓ Sell | 5,000 | $300.94 | $1.5M | Direct | Nov 5, 2024 (4d) |
| Apr 1, 2024 | MDGL | ↓ Sell | 11,000 | $257.48 | $2.8M | Direct | Apr 3, 2024 (2d) |
| Jan 17, 2023 | MDGL | ↓ Sell | 22,489 | $293.15 | $6.6M | Direct | Jan 19, 2023 (2d) |
| Mar 20, 2020 | KOD | ↑ Buy | 1,000 | $44.33 | $44K | Direct | Mar 24, 2020 (4d) |
| Aug 23, 2017 | MDGL | ↑ Buy | 2,000 | $16.12 | $32K | Direct | Aug 24, 2017 (1d) |
| Aug 22, 2017 | MDGL | ↑ Buy | 3,550 | $16.12 | $57K | Direct | Aug 23, 2017 (1d) |
| Aug 21, 2017 | MDGL | ↑ Buy | 3,550 | $15.88 | $56K | Direct | Aug 22, 2017 (1d) |
| Jan 6, 2016 | INCY | ↓ Sell10b5-1 | 3,937 | $101.86 | $401K | Direct | Jan 8, 2016 (2d) |
| Dec 7, 2015 | INCY | ↓ Sell10b5-1 | 3,937 | $106.18 | $418K | Direct | Dec 9, 2015 (2d) |
| Nov 6, 2015 | INCY | ↓ Sell10b5-1 | 3,936 | $116.51 | $459K | Direct | Nov 10, 2015 (4d) |
| Oct 6, 2015 | INCY | ↓ Sell10b5-1 | 3,937 | $122.29 | $481K | Direct | Oct 8, 2015 (2d) |
| Sep 11, 2015 | INCY | ↓ Sell10b5-1 | 4,301 | $130.00 | $559K | Direct | Sep 15, 2015 (4d) |
| Sep 8, 2015 | INCY | ↓ Sell10b5-1 | 3,937 | $118.90 | $468K | Direct | Sep 10, 2015 (2d) |
| Aug 6, 2015 | INCY | ↓ Sell10b5-1 | 3,936 | $111.95 | $441K | Direct | Aug 10, 2015 (4d) |
| Jul 15, 2015 | INCY | ↓ Sell10b5-1 | 70,217 | $120.00 | $8.4M | Direct | Jul 16, 2015 (1d) |
| Jul 6, 2015 | INCY | ↓ Sell10b5-1 | 3,937 | $107.00 | $421K | Direct | Jul 8, 2015 (2d) |
| Jun 19, 2015 | INCY | ↓ Sell10b5-1 | 20,000 | $108.13 | $2.2M | Direct | Jun 23, 2015 (4d) |
| Jun 8, 2015 | INCY | ↓ Sell10b5-1 | 3,937 | $107.58 | $424K | Direct | Jun 10, 2015 (2d) |
| May 6, 2015 | INCY | ↓ Sell10b5-1 | 7,412 | $99.43 | $737K | Direct | May 8, 2015 (2d) |
| Apr 6, 2015 | INCY | ↓ Sell10b5-1 | 25,000 | $88.77 | $2.2M | Direct | Apr 8, 2015 (2d) |
| Mar 6, 2015 | INCY | ↓ Sell10b5-1 | 25,000 | $89.91 | $2.2M | Direct | Mar 10, 2015 (4d) |
| Feb 17, 2015 | INCY | ↓ Sell10b5-1 | 12,000 | $76.90 | $923K | Direct | Feb 18, 2015 (1d) |
| Feb 6, 2015 | INCY | ↓ Sell10b5-1 | 25,000 | $75.11 | $1.9M | Direct | Feb 10, 2015 (4d) |
| Jan 16, 2015 | INCY | ↓ Sell10b5-1 | 12,000 | $73.07 | $877K | Direct | Jan 20, 2015 (4d) |
| Jan 6, 2015 | INCY | ↓ Sell10b5-1 | 25,000 | $71.84 | $1.8M | Direct | Jan 8, 2015 (2d) |
| Dec 16, 2014 | INCY | ↓ Sell10b5-1 | 12,000 | $72.36 | $868K | Direct | Dec 18, 2014 (2d) |
| Nov 17, 2014 | INCY | ↓ Sell10b5-1 | 12,000 | $69.97 | $840K | Direct | Nov 19, 2014 (2d) |
| Oct 16, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $49.03 | $392K | Direct | Oct 20, 2014 (4d) |
| Sep 16, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $47.58 | $381K | Direct | Sep 18, 2014 (2d) |
| Aug 18, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $51.97 | $416K | Direct | Aug 19, 2014 (1d) |
| Jul 16, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $48.15 | $385K | Direct | Jul 18, 2014 (2d) |
| Jun 16, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $53.88 | $431K | Direct | Jun 18, 2014 (2d) |
| May 16, 2014 | INCY | ↓ Sell10b5-1 | 8,000 | $50.68 | $405K | Direct | May 20, 2014 (4d) |
| Feb 14, 2014 | INCY | ↓ Sell | 231,096 | $66.34 | $15.3M | Direct | Feb 18, 2014 (4d) |
| Sep 6, 2013 | INCY | ↓ Sell | 25,000 | $35.28 | $882K | Direct | Sep 9, 2013 (3d) |
| May 13, 2013 | INCY | ↓ Sell | 55,699 | $22.30 | $1.2M | Direct | May 15, 2013 (2d) |
| Feb 15, 2013 | INCY | ↓ Sell | 98,440 | $22.48 | $2.2M | Direct | Feb 20, 2013 (5d) |
| Apr 27, 2012 | INCY | ↓ Sell | 30,000 | $22.95 | $689K | Direct | May 1, 2012 (4d) |
| Jan 18, 2011 | INCY | ↓ Sell | 40,310 | $15.80 | $637K | Direct | Jan 20, 2011 (2d) |
| Mar 15, 2010 | INCY | ↓ Sell | 20,000 | $12.94 | $259K | Direct | Mar 17, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MDGL insiders
Open-market trades in the last 12 months
About Richard S Levy's insider trades
Richard S Levy is a director at Madrigal Pharmaceuticals (MDGL). Since Mar 15, 2010, Richard has reported 5 open-market purchases worth $254K and 39 sales worth $70.7M on SEC Form 4. In the last 12 months: 2 sales ($7.4M).
26 sales (42% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (52 filings), option exercises (51 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.